Citations to this article
Citation Information: J Clin Invest. 2007;117(5):1175-1183. https://doi.org/10.1172/JCI31537.
Abstract
It has been established that cancer can be promoted and/or exacerbated by inflammation and infections. Indeed, chronic inflammation orchestrates a tumor-supporting microenvironment that is an indispensable participant in the neoplastic process. The mechanisms that link infection, innate immunity, inflammation, and cancer are being unraveled at a fast pace. Important components in this linkage are the cytokines produced by activated innate immune cells that stimulate tumor growth and progression. In addition, soluble mediators produced by cancer cells recruit and activate inflammatory cells, which further stimulate tumor progression. However, inflammatory cells also produce cytokines that can limit tumor growth. Here we provide an overview of the current understanding of the role of inflammation-induced cytokines in tumor initiation, promotion, and progression.
Authors
Wan-Wan Lin, Michael Karin
Total citations by year
Citations to this article in year 2007 (3)
| Title and authors | Publication | Year |
|---|---|---|
|
Series overview: Harnessing the immune system to treat cancer
Nina Bhardwaj |
Journal of Clinical Investigation | 2007 |
|
CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the aged
S Sharma, AL Dominguez, DB Hoelzinger, J Lustgarten |
Cancer Immunology, Immunotherapy | 2007 |
|
Ovarian Cancer Biomarkers: A Focus on Genomic and Proteomic Findings
A Tinelli, D Vergara, R Martignago, G Leo, A Malvasi, R Tinelli, S Marsigliante, M Maffia, V Lorusso |
Current genomics | 2007 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)